In melanoma cell lines A375, A2058, and RPMI-7951, apigenin resulted in decreased G1 and S phase cell counts alongside decreased levels of IFN-γ and STAT1 phosphorylation while enhancing T cell activity and upregulating IL-2 levels [219, 271]. This evidence concerns the gene IFNG and melanoma.